螞蟻AI健康助手「AQ」累計服務1億個用戶
螞蟻集團公佈,今年6月正式推出的AI健康應用「AQ」,自去年9月開展公開測試以來,已累計1億個用戶。AQ旨在協助用戶管理日常醫療需求,提供包括醫生推薦、醫療報告解讀、個性化健康建議等逾100項AI驅動服務,並接入全國超過5,000間醫療機構、近100萬醫生資源,以及與頂尖醫療專家共同研發的269個AI醫生助理。
螞蟻集團首席執行官韓歆毅表示,在通用人工智能發展的時代,集團將聚焦AI應用創新,通過技術突破改善大衆生活品質。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.